Arcadia Capital Advises InformedDNA on Divestiture of Genetic Testing Utilization Management Business Unit to Zyter
Arcadia Capital acted as the exclusive financial advisor to InformedDNA in the sale of its Genetic Testing Utilization Management business unit to Zyter, a subsidiary of Infinite. This transaction aligns with InformedDNA’s strategy to focus on its core investments and expand its focus on Digital Health.
MIAMI–(BUSINESS WIRE)– #AI–Arcadia Capital, the premier strategic advisor and investment bank to leaders in the tech and tech services ecosystem, served as exclusive financial advisor to InformedDNA (“IDNA” or “the Company”), a portfolio company of Truehelm and QHP Capital, in the divestiture of its Genetic Testing Utilization Management (“GTUM”) business unit to Zyter, a subsidiary of Infinite, a global technology company. The transaction marks the Company’s continued investment in and focus on D